ADRB2 and chronic obstructive pulmonary disease: In a recent study, authors focused on salmeterol, a β2AR-targeted drug used for the treatment of asthma and chronic obstructive pulmonary disease.32 They report that limited βarr recruitment of salmeterol is linked to reduced contacts with N6.55 in the β2AR which is in line with the proposed mechanism.